BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27601233)

  • 1. Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study.
    Liu W; Chen S; Liu B
    Pediatr Surg Int; 2016 Nov; 32(11):1059-1065. PubMed ID: 27601233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma.
    Jiao C; Jiao X; Zhu A; Ge J; Xu X
    J Pediatr Surg; 2017 Apr; 52(4):618-624. PubMed ID: 28277300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
    Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
    World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glypican 3 as a Serum Marker for Hepatoblastoma.
    Zhou S; O'Gorman MR; Yang F; Andresen K; Wang L
    Sci Rep; 2017 Apr; 7():45932. PubMed ID: 28378832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
    Sohn W; Kim J; Kang SH; Yang SR; Cho JY; Cho HC; Shim SG; Paik YH
    Exp Mol Med; 2015 Sep; 47(9):e184. PubMed ID: 26380927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
    Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined low miR-34s are associated with unfavorable prognosis in children with hepatoblastoma: A Chinese population-based study.
    Jiao C; Zhu A; Jiao X; Ge J; Xu X
    J Pediatr Surg; 2016 Aug; 51(8):1355-61. PubMed ID: 27046304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma.
    Xue X; Zhao Y; Wang X; Qin L; Hu R
    J Cell Biochem; 2019 Jan; 120(1):135-142. PubMed ID: 30238497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
    Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
    Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
    Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
    Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma.
    Shi M; Jiang Y; Yang L; Yan S; Wang YG; Lu XJ
    J Cell Biochem; 2018 Jun; 119(6):4711-4716. PubMed ID: 29278659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma.
    Takahasi K; Iinuma H; Wada K; Minezaki S; Kawamura S; Kainuma M; Ikeda Y; Shibuya M; Miura F; Sano K
    J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):155-161. PubMed ID: 29130611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer.
    Zhang W; Su X; Li S; Liu Z; Wang Q; Zeng H
    Cancer Biomark; 2020; 27(4):485-491. PubMed ID: 32065786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.
    Wang J; Yan F; Zhao Q; Zhan F; Wang R; Wang L; Zhang Y; Huang X
    Sci Rep; 2017 Jun; 7(1):4150. PubMed ID: 28646161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
    Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary Exosomal miR-193a Can Be a Potential Biomarker for the Diagnosis of Primary Focal Segmental Glomerulosclerosis in Children.
    Huang Z; Zhang Y; Zhou J; Zhang Y
    Biomed Res Int; 2017; 2017():7298160. PubMed ID: 28246603
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma.
    Wang H; Hou L; Li A; Duan Y; Gao H; Song X
    Biomed Res Int; 2014; 2014():864894. PubMed ID: 24963487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.